CLINICAL ASSESSMENT OF SAFETY, PHARMACOKINETICS, AND EFFICACY OF IMMUNE GLOBULIN INTRAVENOUS 10% IN PEDIATRIC PATIENTS

被引:0
|
作者
Melamed, I.
Walter, J.
Alpan, O.
Jhaveri, D.
Koterba, A.
Leiding, J.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P167
引用
收藏
页码:S64 / S64
页数:1
相关论文
共 50 条
  • [21] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Richard L. Wasserman
    Joseph A. Church
    Mark Stein
    James Moy
    Martha White
    Steven Strausbaugh
    Harry Schroeder
    Mark Ballow
    James Harris
    Isaac Melamed
    David Elkayam
    William Lumry
    Daniel Suez
    Syed M. Rehman
    Journal of Clinical Immunology, 2012, 32 : 663 - 669
  • [22] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Wasserman, Richard L.
    Church, Joseph A.
    Stein, Mark
    Moy, James
    White, Martha
    Strausbaugh, Steven
    Schroeder, Harry
    Ballow, Mark
    Harris, James
    Melamed, Isaac
    Elkayam, David
    Lumry, William
    Suez, Daniel
    Rehman, Syed M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (04) : 663 - 669
  • [23] Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
    Apte, Shashikant
    Navarro-Puerto, Jordi
    Damodar, Sharat
    Ramanan, Vijay
    John, Joseph
    Kato, Giraldo
    Ross, Cecil
    Shah, Chirag
    Torres, Marcela
    Fu, Chieh-Lin 'Kathy'
    Rucker, Karen
    Pinciaro, Paul
    Barrera, Gladis
    Esperanca Aragones, Maria
    Ayguasanosa, Jaume
    IMMUNOTHERAPY, 2019, 11 (02) : 81 - 89
  • [24] Safety of intravenous immune globulin in an outpatient setting for patients with neuromuscular disease
    Waheed, Waqar
    Ayer, Gretchen A.
    Jadoo, Cindy L.
    Badger, Gary J.
    Aboukhatwa, Marwa
    Brannagan, Thomas H., III
    Tandan, Rup
    MUSCLE & NERVE, 2019, 60 (05) : 528 - 537
  • [25] Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
    Wasserman, Richard L.
    Melamed, Isaac
    Kobrynski, Lisa
    Strausbaugh, Steven D.
    Stein, Mark R.
    Sharkhawy, Marlies
    Engl, Werner
    Leibl, Heinz
    Sobolevsky, Luba
    Gelmont, David
    Schiff, Richard I.
    Grossman, William J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 323 - 331
  • [26] Safety, Efficacy, and Pharmacokinetics of Telmisartan in Pediatric Patients With Hypertension
    Wells, Thomas G.
    Portman, Ronald
    Norman, Patricia
    Haertter, Sebastian
    Davidai, Giora
    Wang, Fei
    CLINICAL PEDIATRICS, 2010, 49 (10) : 938 - 946
  • [27] Pharmacokinetics, Safety and Efficacy of Voriconazole in Pediatric Patients: An Update
    Charalampos Dokos
    Stephanie Pieper
    Thomas Lehrnbecher
    Andreas H. Groll
    Current Fungal Infection Reports, 2012, 6 (2) : 121 - 126
  • [28] Pharmacokinetics, Safety and Efficacy of Voriconazole in Pediatric Patients: An Update
    Dokos, Charalampos
    Pieper, Stephanie
    Lehrnbecher, Thomas
    Groll, Andreas H.
    CURRENT FUNGAL INFECTION REPORTS, 2012, 6 (02) : 121 - 126
  • [29] Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
    Richard L. Wasserman
    Isaac Melamed
    Lisa Kobrynski
    Steven D. Strausbaugh
    Mark R. Stein
    Marlies Sharkhawy
    Werner Engl
    Heinz Leibl
    Luba Sobolevsky
    David Gelmont
    Richard I. Schiff
    William J. Grossman
    Journal of Clinical Immunology, 2011, 31 : 323 - 331
  • [30] IV IMMUNE GLOBULIN - EFFICACY AND SAFETY
    MINNEFOR, AB
    OLESKE, JM
    HOSPITAL PRACTICE, 1987, 22 (10): : 171 - &